Affiliation:
1. Department of Agriculture Sciences, University of Naples Federico II, 80055 Naples, Italy
Abstract
Gut microbiota regulates essential processes of host metabolism and physiology: synthesis of vitamins, digestion of foods non-digestible by the host (such as fibers), and—most important—protects the digestive tract from pathogens. In this study, we focus on the CRISPR/Cas9 technology, which is extensively used to correct multiple diseases, including liver diseases. Then, we discuss the non-alcoholic fatty liver disease (NAFLD), affecting more than 25% of the global population; colorectal cancer (CRC) is second in mortality. We give space to rarely discussed topics, such as pathobionts and multiple mutations. Pathobionts help to understand the origin and complexity of the microbiota. Since several types of cancers have as target the gut, it is vital extending the research of multiple mutations to the type of cancers affecting the gut–liver axis.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference91 articles.
1. Host-bacterial mutualism in the human intestine;Ley;Science,2005
2. Inflammatory disease caused by intestinal pathobionts;Zechner;Curr. Opin. Microbiol.,2017
3. Intestinal microbiota and nonalcoholic steatohepatitis;Brandl;Curr. Opin. Gastroenterol.,2017
4. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease;Salguero;Exp. Ther. Med.,2019
5. Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases;Ferreira;Mol. Genet. Metab.,2019
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献